← back to search

Anna Henningham

The University of Queensland · AU
Area of research
Public Health, Environmental and Occupational Health · Infectious Diseases
Research interest
Research interests include Streptococcal Infections and Treatments, Neonatal and Maternal Infections, Antimicrobial Resistance in Staphylococcus, and Infective Endocarditis Diagnosis and Management.
h-index
21
citations
2,817
works
37
NIH funding
primary concept
email

Recent publications

Virulence Role of the GlcNAc Side Chain of the Lancefield Cell Wall Carbohydrate Antigen in Non-M1-Serotype Group A<i>Streptococcus</i>
mBio 2018cited by 61position: firstdoi
Streptococcal Lancefield polysaccharides are critical cell wall determinants for human Group IIA secreted phospholipase A2 to exert its bactericidal effects
PLoS Pathogens 2018cited by 35position: middledoi
Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models
mBio 2016cited by 66position: middledoi
Streptococcal toxins: role in pathogenesis and disease
Cellular Microbiology 2015cited by 105position: middledoi
Mechanisms of group A<i>Streptococcus</i>resistance to reactive oxygen species
FEMS Microbiology Reviews 2015cited by 92position: firstdoi
Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activation
Journal of Molecular Medicine 2015cited by 89position: middledoi
Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Clinical Microbiology Reviews 2014cited by 912position: middledoi
A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine Development
The Journal of Infectious Diseases 2014cited by 316position: middledoi
The Classical Lancefield Antigen of Group A Streptococcus Is a Virulence Determinant with Implications for Vaccine Design
Cell Host & Microbe 2014cited by 158position: middledoi
Mutual Exclusivity of Hyaluronan and Hyaluronidase in Invasive Group A Streptococcus
Journal of Biological Chemistry 2014cited by 40position: firstdoi
Structure-Informed Design of an Enzymatically Inactive Vaccine Component for Group A <i>Streptococcus</i>
mBio 2013cited by 72position: firstdoi
Conserved anchorless surface proteins as group A streptococcal vaccine candidates
Journal of Molecular Medicine 2012cited by 61position: firstdoi
Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone
The FASEB Journal 2012cited by 57position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Victor Nizet · CNR de la Résistance aux Antibiotiques11 papers (2012–2018)Jason N. Cole · University of California San Diego10 papers (2012–2018)Mark J. Walker · The University of Queensland10 papers (2012–2018)Christine M. Gillen · University of Wollongong4 papers (2012–2016)Samira Dahesh · University of California San Diego3 papers (2014–2015)Biswa Choudhury · University of California San Diego3 papers (2014–2016)Martina Sanderson‐Smith · University of Wollongong3 papers (2012–2014)Timothy C. Barnett · The University of Western Australia3 papers (2012–2015)Ramy K. Aziz · Cairo University3 papers (2012–2014)Michael R. Batzloff · Griffith University3 papers (2012–2016)Nina M. van Sorge · Amsterdam University Medical Centers3 papers (2014–2018)Amanda J. Cork · University of Wollongong3 papers (2012–2016)Boštjan Kobe · University of Queensland2 papers (2012–2013)Tania Rivera-Hernández · University of Queensland2 papers (2015–2016)Mark R. Davies · London School of Hygiene & Tropical Medicine2 papers (2014–2018)Kirsten Kuipers · New York University2 papers (2014–2014)Scott A. Beatson · The University of Queensland2 papers (2012–2014)Nouri L. Ben Zakour · The University of Queensland2 papers (2012–2014)Jason D. McArthur · University of Wollongong2 papers (2012–2014) · 2 papers (2014–2014)